Stephen F. Flatt - Feb 24, 2025 Form 4 Insider Report for NATIONAL HEALTHCARE CORP (NHC)

Role
CEO, Director
Signature
/s/ Stephen F. Flatt
Stock symbol
NHC
Transactions as of
Feb 24, 2025
Transactions value $
$0
Form type
4
Date filed
2/26/2025, 05:44 PM
Previous filing
Jan 3, 2025
Next filing
Mar 6, 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding NHC Common Stock 54.7K Feb 24, 2025 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction NHC Option to Purchase Common Stock Award $0 +18K $0.00 18K Feb 24, 2025 Common Stock 18K $90.62 Direct F1, F2
holding NHC Option to Purchase Common Stock 4.73K Feb 24, 2025 Common Stock 4.73K $63.96 Direct
holding NHC Option to Purchase Common Stock 10K Feb 24, 2025 Common Stock 10K $53.94 Direct
holding NHC Option to Purchase Common Stock 15K Feb 24, 2025 Common Stock 15K $94.10 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These stock options were granted pursuant to the 2020 Omnibus Equity Incentive Plan on February 24, 2025. The grant and exercise of these stock options are exempt from Section 16(b) pursuant to Rule 16b-3(d).
F2 These stock options will become vested and exercisable ratably over three (3) years so that one-third (1/3) will vest on February 24, 2026; one-third (1/3) will vest on February 24, 2027; and the final one-third (1/3) will vest on February 24, 2028.